The FDA announced the resignations of Marion Gruber and Philip Krause on Tuesday.
- Dr. Marion Gruber, the director of the FDA’s Office of Vaccines Research and Review, and her deputy, Dr. Philip Krause, plan to leave the FDA in October and November. BioCentury first reported the news on Tuesday.
- In a letter announcing the resignations obtained by the biotech-industry publication Endpoints, Dr. Peter Marks, the director of the FDA’s Center for Biologics Evaluation and Research, praised the pair for their work during the COVID-19 pandemic. He didn’t give a reason for their departures.
- One former senior FDA leader told Endpoints that Gruber and Krause were leaving because they felt that the Centers for Disease Control and Prevention was making vaccine decisions that should have been left to the FDA and were upset with Marks, the leader of their division, for not insisting on the agency’s oversight.